Stock Events

Stock Events

BioPharma Credit 

$0.9697
173
-$0.03-3.04%Wednesday 18:47

Statistics

Day High
1.01
Day Low
1.01
52W High
1.02
52W Low
0.8503
Volume
376
Avg. Volume
33,394
Mkt Cap
0
P/E Ratio
16.29
Dividend Yield
7.11%
Dividend
0.07

Upcoming

Dividends

7.11%Dividend Yield
Nov 2026
$0.02
Jul 2026
$0.02
May 2026
$0.02
Mar 2026
$0.01
Mar 2026
$0.02
10Y Growth
N/A
5Y Growth
-0.1%
3Y Growth
-0.31%
1Y Growth
1.07%

Earnings

Sep 25Expected
Q4 2021
Q2 2022
Q4 2022
Q2 2023
Q4 2023
Q1 2024
Q2 2024
0.03
0.04
0.04
0.05
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BOPCF. It's not an investment recommendation.
Legal & General Group
34
LGEN.LSE
Greencoat UK Wind
26
UKW.LSE
Aviva
24
AV.LSE
The Renewables Infrastructure Group Limited
23
TRIG.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BridgeBio Pharma
BBIO
Mkt Cap13.15B
BridgeBio Pharma focuses on genetic diseases and competes in the biopharma financing space by attracting investments for its projects.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a large pharmaceutical company with a significant investment arm for biopharma ventures, competing for similar investment opportunities.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences invests in biopharma companies and projects, directly competing with BioPharma Credit's investment model.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb, through its venture arm, competes in the biopharma credit and investment space.
Merck
MRK
Mkt Cap356.01B
Merck & Co., with its venture capital initiatives, competes for similar biopharma investments and financing opportunities.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson, through its J&J Innovation and JLABS units, competes in the biopharma investment and financing space.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie, with its venture investment arm, competes for opportunities in biopharma credit and financing.
AMGEN
AMGN
Mkt Cap217.9B
Amgen, through its venture investments, competes in the biopharma financing space, targeting similar companies and projects.
Novartis
NVS
Mkt Cap268B
Novartis, with its significant investments in biopharma companies, competes directly with BioPharma Credit's financing model.
Sanofi
SNY
Mkt Cap95.65B
Sanofi, through its venture capital arm, competes in the biopharma credit market, financing similar types of companies and projects.

About

Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.
Show More
CEO
Pedro Gonzalez de Cosio
Employees
15
Country
United Kingdom
ISIN
GB00BDGKMY29
WKN
000A2DN3S

Listings

OTC Link
US
BOPCF
STU
DE
B3P.STU
MU
DE
BPCR.MU
LSE
GB
BPCP.LSE

0 Comments

Share your thoughts

FAQs

What is BioPharma Credit stock price today?▼
The current price of BOPCF is $0.97 USD — it has decreased by -3.04% in the past 24 hours. Watch BioPharma Credit stock price performance more closely on the chart.
What is BioPharma Credit stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BioPharma Credit stocks are traded under the ticker BOPCF.
Is BioPharma Credit stock price growing?▼
BOPCF stock has risen by +0% compared to the previous week, the month change is a -3.04% fall, over the last year BioPharma Credit has showed a +5.34% increase.
What were BioPharma Credit earnings last quarter?▼
BOPCF earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does BioPharma Credit pay dividends?▼
Yes, BOPCF dividends are paid quarterly. The last dividend per share was 0.02 . As of today, Dividend Yield (FWD)% is 7.11%.
How many employees does BioPharma Credit have?▼
As of October 28, 2026, the company has 15 employees.
In which sector is BioPharma Credit located?▼
BioPharma Credit operates in the Finance & Payments sector.
When did BioPharma Credit complete a stock split?▼
BioPharma Credit has not had any recent stock splits.
Where is BioPharma Credit headquartered?▼
BioPharma Credit is headquartered in London, United Kingdom.